Physician profile
Krishna Goli
NPI 1932384427
$8,246.69
in general payments reported to CMS, 2019-2025
63 companies · $1,619 in 2025
The $1,619 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,663 · 2020: $702 · 2021: $848 · 2022: $827 · 2023: $654 · 2024: $934 · 2025: $1,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,028 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,028.07 |
| Education | $179.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $734.77 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Abbvie INC. | $734.56 | 2019-2025 | |
| Biogen, INC. | $571.89 | 2019-2025 | Tysabri, Vumerity, Leqembi |
| Novartis Pharmaceuticals Corporation | $523.35 | 2019-2025 | |
| Allergan, INC. | $460.27 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $419.01 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Amgen INC. | $293.25 | 2019-2025 | Uplizna |
| Greenwich Biosciences, INC. | $263.29 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $235.25 | 2019-2024 | Ultomiris, Soliris |
| Mdd US Operations, LLC | $220.15 | 2019-2025 | Gocovri |
| Genzyme Corporation | $217.49 | 2019-2022 | |
| Pfizer INC. | $193.73 | 2023-2025 | |
| Lilly USA, LLC | $181.62 | 2019-2024 | Amyvid, Kisunla, Emgality |
| Sunovion Pharmaceuticals INC. | $157.79 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $151.31 | 2019-2025 | Nuplazid |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Goli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.